DexCom, Inc. (0A4M)
LSE
85.46
+3.43 (+4.18%)
Closed
Aug 5, 2026
Day's Range
85.4685.46
52 wk Range
56.0085.46
Financial Statements - 0A4M - DexCom, Inc.
Revenue
58.75B▲ 14.0%
Net Income
7.72B▲ 76.0%Net Margin 13.1%
EBITDA
12.64B▲ 26.0%
Free Cash Flow
5.38B▼ 15.9%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 58.75B | 51.53B | 51.33B | 46.67B |
| Cost of Goods | 9.48B | 8.36B | 8.48B | 7.72B |
| Gross Profit | 49.27B | 43.16B | 42.85B | 38.95B |
 Operating Expense | - | - | - | - |
| Operating Income | 9.67B | 7.26B | 7.21B | 6.64B |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | 1.72B | -248M | -150M | 448M |
| Pre Tax Income | 9.83B | 5.43B | 5.24B | 5.33B |
| Income Tax | 2.11B | 1.04B | 1.09B | 946M |
| Net Income | 7.72B | 4.38B | 4.14B | 4.38B |
| EPS Basic | 22.77096 | 11.059861 | 10.356169 | 11.044191 |
| EPS Diluted | 21.16 | 10.93 | 10.07 | 10.66 |
| Basic Shares Outstanding | 305.47M | 339.42M | 338.44M | 342.89M |
| Diluted Shares Outstanding | 305.47M | 339.42M | 338.44M | 342.89M |
| Ebit | - | - | - | - |
| Ebitda | 12.64B | 10.03B | 9.85B | 8.94B |
| Net Income Continuous Operations | 7.72B | 4.38B | 4.14B | 4.38B |
| Minority Interests | -765M | -633M | -640M | -602M |
| Preferred Stock Dividends | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
